Quantum mechanical/molecular mechanical (QM/MM) docking: an evaluation for known test systems

A combined quantum mechanical/molecular mechanical (QM/MM) docking approach for the investigation of protein-inhibitor complexes is presented. Starting points for QM/MM optimizations are generated with AutoDock. The subsequent semiempirical AMI QM/MM optimization of the complex obtained by the docking procedure gives a more detailed description of the binding mode and the electronic properties of the ligand. As we use a flexible protein environment in the QM/MM optimizations, we are able to simulate limited structural changes of the enzyme upon binding a ligand, even within a simple geometry optimization. The method was validated using a set of structurally known protein-inhibitor complexes, whose crystallographic data were taken from the Protein Data Bank. In addition to protein structures taken directly from complexes with the inhibitors, structures of uncomplexed HIV-1-protease and thrombin were also used successfully for QM/MM docking experiments. By comparing the resulting structures with those obtained using protein structures from protein-inhibitor complexes, we find that the method is able to simulate the effect of the induced fit when a simple optimization is adequate to reproduce the protein movement. Describing the ligand quantum mechanically gives a detailed view of its electronic properties, for example its polarization within the active site of the enzyme. This study suggests strongly that a QM/MM molecular dynamics approach will be able to simulate the induced fit in general cases.

[1]  Haiyan Liu,et al.  The reaction pathway of the isomerization of d‐xylose catalyzed by the enzyme d‐xylose isomerase: A theoretical study , 1997, Proteins.

[2]  I. Weber,et al.  Comparison of inhibitor binding in HIV‐1 protease and in non‐viral aspartic proteases: the role of the flap , 1990, FEBS letters.

[3]  John P. Overington,et al.  X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes , 1989, Nature.

[4]  Gennady M Verkhivker,et al.  Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. , 1995, Chemistry & biology.

[5]  R. Wade,et al.  Computational approaches to modeling receptor flexibility upon ligand binding: Application to interfacially activated enzymes , 1998 .

[6]  Anselm H. C. Horn,et al.  The Reaction Mechanism of Bovine Lens Leucine Aminopeptidase. , 2002, The journal of physical chemistry. B.

[7]  Malin M. Young,et al.  Design, docking, and evaluation of multiple libraries against multiple targets , 2001, Proteins.

[8]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[9]  W. Lipscomb,et al.  X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Katz,et al.  Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator. , 2000, Chemistry & biology.

[11]  Ajit Banerjee,et al.  Search for stationary points on surfaces , 1985 .

[12]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[13]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[14]  S. Navea,et al.  Modeling cyclooxygenase inhibition. Implication of active site hydration on the selectivity of ketoprofen analogues. , 2000, Journal of medicinal chemistry.

[15]  H. Kubinyi,et al.  3D QSAR in drug design. , 2002 .

[16]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[17]  Adrian J. Mulholland,et al.  Ab initio QM/MM study of the citrate synthase mechanism. A low-barrier hydrogen bond is not involved , 2000 .

[18]  C. Ehrhardt,et al.  Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors. , 1998, Journal of medicinal chemistry.

[19]  P. Seybold,et al.  Substituent effects on the physical properties and pKa of aniline , 2000 .

[20]  W. V. Gunsteren,et al.  The elucidation of enzymatic reaction mechanisms by computer simulation: Human immunodeficiency virus protease catalysis , 1998 .

[21]  Jorge Nocedal,et al.  On the limited memory BFGS method for large scale optimization , 1989, Math. Program..

[22]  M. Schlitzer,et al.  Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors. , 2001, Journal of medicinal chemistry.

[23]  P. Kollman,et al.  An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.

[24]  K D Watenpaugh,et al.  Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. , 1995, Journal of medicinal chemistry.

[25]  T. Bishop,et al.  Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. , 2001, Journal of medicinal chemistry.

[26]  Gerhard Klebe,et al.  Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation. , 2002, Journal of medicinal chemistry.

[27]  D. E. Clark,et al.  Flexible docking using tabu search and an empirical estimate of binding affinity , 1998, Proteins.

[28]  Elena Conti,et al.  X‐ray and spectrophotometric studies of the binding of proflavin to the S1 specificity pocket of human α‐thrombin , 1998 .

[29]  A Tropsha,et al.  Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking. , 2001, Journal of molecular graphics & modelling.

[30]  A. N. Jain,et al.  Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. , 1996, Chemistry & biology.

[31]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[32]  Vicent Moliner,et al.  Catalytic Mechanism of Dihydrofolate Reductase Enzyme. A Combined Quantum-Mechanical/Molecular-Mechanical Characterization of Transition State Structure for the Hydride Transfer Step , 1999 .

[33]  A. Lledós,et al.  Theoretical Study on the Origin of Enantioselectivity in the Bis(dihydroquinidine)-3,6-pyridazine·Osmium Tetroxide-Catalyzed Dihydroxylation of Styrene , 1999 .

[34]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[35]  I. Kuntz,et al.  Flexible ligand docking: A multistep strategy approach , 1999, Proteins.

[36]  Tingjun Hou,et al.  Automated docking of peptides and proteins by using a genetic algorithm combined with a tabu search. , 1999, Protein engineering.

[37]  W. Shin,et al.  The X-ray structure of Aspergillus aculeatus polygalacturonase and a modeled structure of the polygalacturonase-octagalacturonate complex. , 2001, Journal of molecular biology.

[38]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[39]  T Lengauer,et al.  Two-stage method for protein-ligand docking. , 1999, Journal of medicinal chemistry.

[40]  J. Gready,et al.  Molecular dynamics and free energy perturbation study of hydride‐ion transfer step in dihydrofolate reductase using combined quantum and molecular mechanical model , 1998 .

[41]  P. Finn,et al.  Fast and accurate predictions of relative binding energies , 1997 .

[42]  T Lengauer,et al.  The particle concept: placing discrete water molecules during protein‐ligand docking predictions , 1999, Proteins.

[43]  G. Schürer,et al.  The Mode of Action of Phospholipase A2: Semiempirical MO Calculations Including the Protein Environment , 2000 .

[44]  Colin McMartin,et al.  QXP: Powerful, rapid computer algorithms for structure-based drug design , 1997, J. Comput. Aided Mol. Des..

[45]  M. Levitt,et al.  Theoretical studies of enzymic reactions: dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme. , 1976, Journal of molecular biology.

[46]  D. Goodsell,et al.  Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.

[47]  Jeremy R. H. Tame,et al.  Scoring functions: A view from the bench , 1999, J. Comput. Aided Mol. Des..

[48]  Thomas Lengauer,et al.  Structure Based Drug Design , 2005 .

[49]  R. Wade,et al.  Computational Strategies for Modeling Receptor Flexibility in Studies of Receptor-Ligand Interactions , 1998 .

[50]  A. Leach Molecular Modelling: Principles and Applications , 1996 .

[51]  Marjana Novic,et al.  Prediction of Enzyme Binding: Human Thrombin Inhibition Study by Quantum Chemical and Artificial Intelligence Methods Based on X-ray Structures , 2001, J. Chem. Inf. Comput. Sci..

[52]  K D Watenpaugh,et al.  Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. , 1997, Journal of medicinal chemistry.

[53]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[54]  Arieh Warshel,et al.  Simulation of enzyme reactions using valence bond force fields and other hybrid quantum/classical approaches , 1993 .

[55]  Kenneth M. Merz,et al.  Force Field Design for Metalloproteins , 1991 .

[56]  Lars Ridder,et al.  A Quantum Mechanical/Molecular Mechanical Study of the Hydroxylation of Phenol and Halogenated Derivatives by Phenol Hydroxylase , 2000 .

[57]  G. Klebe,et al.  Subnanomolar wirksame Inhibitoren aus dem Computerscreening: eine Modellstudie an der humanen Carboanhydrase II , 2001 .

[58]  Gennady M Verkhivker,et al.  Predicting structural effects in HIV‐1 protease mutant complexes with flexible ligand docking and protein side‐chain optimization , 1998, Proteins.

[59]  J. Kraut,et al.  Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. , 1997, Biochemistry.

[60]  A. Elcock,et al.  Computer Simulation of Protein−Protein Interactions , 2001 .

[61]  K. Merz,et al.  Combined Quantum Mechanical/Molecular Mechanical Methodologies Applied to Biomolecular Systems , 1999 .

[62]  J. Valverde Molecular Modelling: Principles and Applications , 2001 .

[63]  D. Koshland Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[65]  I. Enyedy,et al.  Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. , 2001, Journal of medicinal chemistry.

[66]  C L Verlinde,et al.  Structure-based drug design: progress, results and challenges. , 1994, Structure.

[67]  Kenneth M. Merz,et al.  CO2 binding to human carbonic anhydrase II , 1991 .

[68]  W. Punch,et al.  Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm. , 1997, Journal of molecular biology.

[69]  S H Kaufmann,et al.  Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads. , 2000, Journal of medicinal chemistry.

[70]  W. Goddard,et al.  UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations , 1992 .

[71]  R. Huber,et al.  The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors , 1983 .

[72]  Thomas Lengauer,et al.  FlexE: efficient molecular docking considering protein structure variations. , 2001, Journal of molecular biology.

[73]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[74]  J. Drews Drug discovery: a historical perspective. , 2000, Science.

[75]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[76]  A Wlodawer,et al.  X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Thomas A. Halgren,et al.  The representation of van der Waals (vdW) interactions in molecular mechanics force fields: potential form, combination rules, and vdW parameters , 1992 .

[78]  PatrickY.-S. Lam,et al.  Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.

[79]  Shaomeng Wang,et al.  MCDOCK: A Monte Carlo simulation approach to the molecular docking problem , 1999, J. Comput. Aided Mol. Des..

[80]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[81]  G. Klebe,et al.  Statistical potentials and scoring functions applied to protein-ligand binding. , 2001, Current opinion in structural biology.

[82]  Bernd Beck,et al.  The natural atomic orbital point charge model for PM3: Multipole moments and molecular electrostatic potentials , 1994, J. Comput. Chem..

[83]  David S. Goodsell,et al.  Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..